Global Bicalutamide Market Growth 2020-2025
According to this study, over the next five years the Bicalutamide market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Bicalutamide business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Bicalutamide market by type, application, key manufacturers and key regions and countries.
This study considers the Bicalutamide value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Tablets
Capsule
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Single Drug For Prostate Cancer
Combined Chemotherapy For Prostate Cancer
Combined Radiation Therapy Or Castration For Prostate Cancer
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AstraZeneca
Apotex Corporation
CORDEN PHARMA GMBH
Actavis Pharma
Sivem Pharmaceuticals
Zeneca GmbH
ANI Pharmaceuticals
Sorres Pharma
Accel Pharma
Fresenius Kabi
Shanghai Fudan Fuhua Pharmaceutical
Shanxi Zhendong Pharmaceutical
Zhejiang Haizheng Pharmaceutical
Shanghai Zhaohui Pharmaceutical
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Bicalutamide consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Bicalutamide market by identifying its various subsegments.
Focuses on the key global Bicalutamide manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Bicalutamide with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Bicalutamide submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bicalutamide Consumption 2015-2025
2.1.2 Bicalutamide Consumption CAGR by Region
2.2 Bicalutamide Segment by Type
2.2.1 Tablets
2.2.2 Capsule
2.3 Bicalutamide Consumption by Type
2.3.1 Global Bicalutamide Consumption Market Share by Type (2015-2020)
2.3.2 Global Bicalutamide Revenue and Market Share by Type (2015-2020)
2.3.3 Global Bicalutamide Sale Price by Type (2015-2020)
2.4 Bicalutamide Segment by Application
2.4.1 Single Drug For Prostate Cancer
2.4.2 Combined Chemotherapy For Prostate Cancer
2.4.3 Combined Radiation Therapy Or Castration For Prostate Cancer
2.5 Bicalutamide Consumption by Application
2.5.1 Global Bicalutamide Consumption Market Share by Type (2015-2020)
2.5.2 Global Bicalutamide Value and Market Share by Type (2015-2020)
2.5.3 Global Bicalutamide Sale Price by Type (2015-2020)
3 Global Bicalutamide by Company
3.1 Global Bicalutamide Sales Market Share by Company
3.1.1 Global Bicalutamide Sales by Company (2018-2020)
3.1.2 Global Bicalutamide Sales Market Share by Company (2018-2020)
3.2 Global Bicalutamide Revenue Market Share by Company
3.2.1 Global Bicalutamide Revenue by Company (2018-2020)
3.2.2 Global Bicalutamide Revenue Market Share by Company (2018-2020)
3.3 Global Bicalutamide Sale Price by Company
3.4 Global Bicalutamide Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Bicalutamide Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Bicalutamide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Bicalutamide by Regions
4.1 Bicalutamide by Regions
4.2 Americas Bicalutamide Consumption Growth
4.3 APAC Bicalutamide Consumption Growth
4.4 Europe Bicalutamide Consumption Growth
4.5 Middle East & Africa Bicalutamide Consumption Growth
5 Americas
5.1 Americas Bicalutamide Consumption by Countries
5.1.1 Americas Bicalutamide Consumption by Countries (2015-2020)
5.1.2 Americas Bicalutamide Value by Countries (2015-2020)
5.2 Americas Bicalutamide Consumption by Type
5.3 Americas Bicalutamide Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Bicalutamide Consumption by Regions
6.1.1 APAC Bicalutamide Consumption by Regions (2015-2020)
6.1.2 APAC Bicalutamide Value by Regions (2015-2020)
6.2 APAC Bicalutamide Consumption by Type
6.3 APAC Bicalutamide Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Bicalutamide by Countries
7.1.1 Europe Bicalutamide Consumption by Countries (2015-2020)
7.1.2 Europe Bicalutamide Value by Countries (2015-2020)
7.2 Europe Bicalutamide Consumption by Type
7.3 Europe Bicalutamide Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Bicalutamide by Countries
8.1.1 Middle East & Africa Bicalutamide Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Bicalutamide Value by Countries (2015-2020)
8.2 Middle East & Africa Bicalutamide Consumption by Type
8.3 Middle East & Africa Bicalutamide Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Bicalutamide Distributors
10.3 Bicalutamide Customer
11 Global Bicalutamide Market Forecast
11.1 Global Bicalutamide Consumption Forecast (2021-2025)
11.2 Global Bicalutamide Forecast by Regions
11.2.1 Global Bicalutamide Forecast by Regions (2021-2025)
11.2.2 Global Bicalutamide Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Bicalutamide Forecast by Type
11.8 Global Bicalutamide Forecast by Application
12 Key Players Analysis
12.1 AstraZeneca
12.1.1 Company Information
12.1.2 Bicalutamide Product Offered
12.1.3 AstraZeneca Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 AstraZeneca Latest Developments
12.2 Apotex Corporation
12.2.1 Company Information
12.2.2 Bicalutamide Product Offered
12.2.3 Apotex Corporation Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Apotex Corporation Latest Developments
12.3 CORDEN PHARMA GMBH
12.3.1 Company Information
12.3.2 Bicalutamide Product Offered
12.3.3 CORDEN PHARMA GMBH Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 CORDEN PHARMA GMBH Latest Developments
12.4 Actavis Pharma
12.4.1 Company Information
12.4.2 Bicalutamide Product Offered
12.4.3 Actavis Pharma Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Actavis Pharma Latest Developments
12.5 Sivem Pharmaceuticals
12.5.1 Company Information
12.5.2 Bicalutamide Product Offered
12.5.3 Sivem Pharmaceuticals Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Sivem Pharmaceuticals Latest Developments
12.6 Zeneca GmbH
12.6.1 Company Information
12.6.2 Bicalutamide Product Offered
12.6.3 Zeneca GmbH Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Zeneca GmbH Latest Developments
12.7 ANI Pharmaceuticals
12.7.1 Company Information
12.7.2 Bicalutamide Product Offered
12.7.3 ANI Pharmaceuticals Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 ANI Pharmaceuticals Latest Developments
12.8 Sorres Pharma
12.8.1 Company Information
12.8.2 Bicalutamide Product Offered
12.8.3 Sorres Pharma Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Sorres Pharma Latest Developments
12.9 Accel Pharma
12.9.1 Company Information
12.9.2 Bicalutamide Product Offered
12.9.3 Accel Pharma Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Accel Pharma Latest Developments
12.10 Fresenius Kabi
12.10.1 Company Information
12.10.2 Bicalutamide Product Offered
12.10.3 Fresenius Kabi Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Fresenius Kabi Latest Developments
12.11 Shanghai Fudan Fuhua Pharmaceutical
12.11.1 Company Information
12.11.2 Bicalutamide Product Offered
12.11.3 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Shanghai Fudan Fuhua Pharmaceutical Latest Developments
12.12 Shanxi Zhendong Pharmaceutical
12.12.1 Company Information
12.12.2 Bicalutamide Product Offered
12.12.3 Shanxi Zhendong Pharmaceutical Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Shanxi Zhendong Pharmaceutical Latest Developments
12.13 Zhejiang Haizheng Pharmaceutical
12.13.1 Company Information
12.13.2 Bicalutamide Product Offered
12.13.3 Zhejiang Haizheng Pharmaceutical Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Zhejiang Haizheng Pharmaceutical Latest Developments
12.14 Shanghai Zhaohui Pharmaceutical
12.14.1 Company Information
12.14.2 Bicalutamide Product Offered
12.14.3 Shanghai Zhaohui Pharmaceutical Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Shanghai Zhaohui Pharmaceutical Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Bicalutamide Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Tablets
Table 5. Major Players of Capsule
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Bicalutamide Consumption Market Share by Type (2015-2020)
Table 8. Global Bicalutamide Revenue by Type (2015-2020) ($ million)
Table 9. Global Bicalutamide Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Bicalutamide Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Bicalutamide Consumption Market Share by Application (2015-2020)
Table 13. Global Bicalutamide Value by Application (2015-2020)
Table 14. Global Bicalutamide Value Market Share by Application (2015-2020)
Table 15. Global Bicalutamide Sale Price by Application (2015-2020)
Table 16. Global Bicalutamide Sales by Company (2017-2019) (M Pcs)
Table 17. Global Bicalutamide Sales Market Share by Company (2017-2019)
Table 18. Global Bicalutamide Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Bicalutamide Revenue Market Share by Company (2017-2019)
Table 20. Global Bicalutamide Sale Price by Company (2017-2019)
Table 21. Global Bicalutamide Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Bicalutamide Products Offered
Table 23. Bicalutamide Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Bicalutamide Consumption by Regions 2015-2020 (M Pcs)
Table 25. Global Bicalutamide Consumption Market Share by Regions 2015-2020
Table 26. Global Bicalutamide Value by Regions 2015-2020 ($ Millions)
Table 27. Global Bicalutamide Value Market Share by Regions 2015-2020
Table 28. Americas Bicalutamide Consumption by Countries (2015-2020) (M Pcs)
Table 29. Americas Bicalutamide Consumption Market Share by Countries (2015-2020)
Table 30. Americas Bicalutamide Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Bicalutamide Value Market Share by Countries (2015-2020)
Table 32. Americas Bicalutamide Consumption by Type (2015-2020) (M Pcs)
Table 33. Americas Bicalutamide Consumption Market Share by Type (2015-2020)
Table 34. Americas Bicalutamide Consumption by Application (2015-2020) (M Pcs)
Table 35. Americas Bicalutamide Consumption Market Share by Application (2015-2020)
Table 36. APAC Bicalutamide Consumption by Countries (2015-2020) (M Pcs)
Table 37. APAC Bicalutamide Consumption Market Share by Countries (2015-2020)
Table 38. APAC Bicalutamide Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Bicalutamide Value Market Share by Regions (2015-2020)
Table 40. APAC Bicalutamide Consumption by Type (2015-2020) (M Pcs)
Table 41. APAC Bicalutamide Consumption Market Share by Type (2015-2020)
Table 42. APAC Bicalutamide Consumption by Application (2015-2020) (M Pcs)
Table 43. APAC Bicalutamide Consumption Market Share by Application (2015-2020)
Table 44. Europe Bicalutamide Consumption by Countries (2015-2020) (M Pcs)
Table 45. Europe Bicalutamide Consumption Market Share by Countries (2015-2020)
Table 46. Europe Bicalutamide Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Bicalutamide Value Market Share by Countries (2015-2020)
Table 48. Europe Bicalutamide Consumption by Type (2015-2020) (M Pcs)
Table 49. Europe Bicalutamide Consumption Market Share by Type (2015-2020)
Table 50. Europe Bicalutamide Consumption by Application (2015-2020) (M Pcs)
Table 51. Europe Bicalutamide Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Bicalutamide Consumption by Countries (2015-2020) (M Pcs)
Table 53. Middle East & Africa Bicalutamide Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Bicalutamide Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Bicalutamide Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Bicalutamide Consumption by Type (2015-2020) (M Pcs)
Table 57. Middle East & Africa Bicalutamide Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Bicalutamide Consumption by Application (2015-2020) (M Pcs)
Table 59. Middle East & Africa Bicalutamide Consumption Market Share by Application (2015-2020)
Table 60. Bicalutamide Distributors List
Table 61. Bicalutamide Customer List
Table 62. Global Bicalutamide Consumption Forecast by Countries (2021-2025) (M Pcs)
Table 63. Global Bicalutamide Consumption Market Forecast by Regions
Table 64. Global Bicalutamide Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Bicalutamide Value Market Share Forecast by Regions
Table 66. Global Bicalutamide Consumption Forecast by Type (2021-2025) (M Pcs)
Table 67. Global Bicalutamide Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Bicalutamide Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Bicalutamide Value Market Share Forecast by Type (2021-2025)
Table 70. Global Bicalutamide Consumption Forecast by Application (2021-2025) (M Pcs)
Table 71. Global Bicalutamide Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Bicalutamide Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Bicalutamide Value Market Share Forecast by Application (2021-2025)
Table 74. AstraZeneca Product Offered
Table 75. AstraZeneca Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2020E)
Table 76. AstraZeneca Main Business
Table 77. AstraZeneca Latest Developments
Table 78. AstraZeneca Basic Information, Company Total Revenue (in $ million), Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 79. Apotex Corporation Product Offered
Table 80. Apotex Corporation Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2020E)
Table 81. Apotex Corporation Main Business
Table 82. Apotex Corporation Latest Developments
Table 83. Apotex Corporation Basic Information, Company Total Revenue (in $ million), Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 84. CORDEN PHARMA GMBH Product Offered
Table 85. CORDEN PHARMA GMBH Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2020E)
Table 86. CORDEN PHARMA GMBH Main Business
Table 87. CORDEN PHARMA GMBH Latest Developments
Table 88. CORDEN PHARMA GMBH Basic Information, Company Total Revenue (in $ million), Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 89. Actavis Pharma Product Offered
Table 90. Actavis Pharma Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2020E)
Table 91. Actavis Pharma Main Business
Table 92. Actavis Pharma Latest Developments
Table 93. Actavis Pharma Basic Information, Company Total Revenue (in $ million), Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 94. Sivem Pharmaceuticals Product Offered
Table 95. Sivem Pharmaceuticals Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2020E)
Table 96. Sivem Pharmaceuticals Main Business
Table 97. Sivem Pharmaceuticals Latest Developments
Table 98. Sivem Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 99. Zeneca GmbH Product Offered
Table 100. Zeneca GmbH Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2020E)
Table 101. Zeneca GmbH Main Business
Table 102. Zeneca GmbH Latest Developments
Table 103. Zeneca GmbH Basic Information, Company Total Revenue (in $ million), Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 104. ANI Pharmaceuticals Product Offered
Table 105. ANI Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 106. ANI Pharmaceuticals Main Business
Table 107. ANI Pharmaceuticals Latest Developments
Table 108. ANI Pharmaceuticals Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2020E)
Table 109. Sorres Pharma Product Offered
Table 110. Sorres Pharma Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2020E)
Table 111. Sorres Pharma Main Business
Table 112. Sorres Pharma Latest Developments
Table 113. Sorres Pharma Basic Information, Company Total Revenue (in $ million), Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 114. Accel Pharma Product Offered
Table 115. Accel Pharma Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2020E)
Table 116. Accel Pharma Main Business
Table 117. Accel Pharma Latest Developments
Table 118. Accel Pharma Basic Information, Company Total Revenue (in $ million), Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 119. Fresenius Kabi Product Offered
Table 120. Fresenius Kabi Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2020E)
Table 121. Fresenius Kabi Main Business
Table 122. Fresenius Kabi Latest Developments
Table 123. Fresenius Kabi Basic Information, Company Total Revenue (in $ million), Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 124. Shanghai Fudan Fuhua Pharmaceutical Product Offered
Table 125. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2020E)
Table 126. Shanghai Fudan Fuhua Pharmaceutical Main Business
Table 127. Shanghai Fudan Fuhua Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Shanghai Fudan Fuhua Pharmaceutical Latest Developments
Table 129. Shanxi Zhendong Pharmaceutical Product Offered
Table 130. Shanxi Zhendong Pharmaceutical Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2020E)
Table 131. Shanxi Zhendong Pharmaceutical Main Business
Table 132. Shanxi Zhendong Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Shanxi Zhendong Pharmaceutical Latest Developments
Table 134. Zhejiang Haizheng Pharmaceutical Product Offered
Table 135. Zhejiang Haizheng Pharmaceutical Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2020E)
Table 136. Zhejiang Haizheng Pharmaceutical Main Business
Table 137. Zhejiang Haizheng Pharmaceutical Latest Developments
Table 138. Zhejiang Haizheng Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. Shanghai Zhaohui Pharmaceutical Product Offered
Table 140. Shanghai Zhaohui Pharmaceutical Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2020E)
Table 141. Shanghai Zhaohui Pharmaceutical Main Business
Table 142. Shanghai Zhaohui Pharmaceutical Latest Developments
Table 143. Shanghai Zhaohui Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Bicalutamide
Figure 2. Bicalutamide Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Bicalutamide Consumption Growth Rate 2015-2025 (M Pcs)
Figure 5. Global Bicalutamide Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Tablets
Figure 7. Product Picture of Capsule
Figure 8. Global Bicalutamide Consumption Market Share by Type (2015-2020)
Figure 9. Global Bicalutamide Value Market Share by Type (2015-2020)
Figure 10. Bicalutamide Consumed in Single Drug For Prostate Cancer
Figure 11. Global Bicalutamide Market: Single Drug For Prostate Cancer (2015-2020) (M Pcs)
Figure 12. Global Bicalutamide Market: Single Drug For Prostate Cancer (2015-2020) ($ Millions)
Figure 13. Bicalutamide Consumed in Combined Chemotherapy For Prostate Cancer
Figure 14. Global Bicalutamide Market: Combined Chemotherapy For Prostate Cancer (2015-2020) (M Pcs)
Figure 15. Global Bicalutamide Market: Combined Chemotherapy For Prostate Cancer (2015-2020) ($ Millions)
Figure 16. Bicalutamide Consumed in Combined Radiation Therapy Or Castration For Prostate Cancer
Figure 17. Global Bicalutamide Market: Combined Radiation Therapy Or Castration For Prostate Cancer (2015-2020) (M Pcs)
Figure 18. Global Bicalutamide Market: Combined Radiation Therapy Or Castration For Prostate Cancer (2015-2020) ($ Millions)
Figure 19. Global Bicalutamide Consumption Market Share by Application (2015-2020)
Figure 20. Global Bicalutamide Value Market Share by Application (2015-2020)
Figure 21. Global Bicalutamide Sales Market Share by Company in 2017
Figure 22. Global Bicalutamide Sales Market Share by Company in 2019
Figure 23. Global Bicalutamide Revenue Market Share by Company in 2017
Figure 24. Global Bicalutamide Revenue Market Share by Company in 2019
Figure 25. Global Bicalutamide Sale Price by Company in 2019
Figure 26. Global Bicalutamide Consumption Market Share by Regions 2015-2020
Figure 27. Global Bicalutamide Value Market Share by Regions 2015-2020
Figure 28. Americas Bicalutamide Consumption 2015-2020 (M Pcs)
Figure 29. Americas Bicalutamide Value 2015-2020 ($ Millions)
Figure 30. APAC Bicalutamide Consumption 2015-2020 (M Pcs)
Figure 31. APAC Bicalutamide Value 2015-2020 ($ Millions)
Figure 32. Europe Bicalutamide Consumption 2015-2020 (M Pcs)
Figure 33. Europe Bicalutamide Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Bicalutamide Consumption 2015-2020 (M Pcs)
Figure 35. Middle East & Africa Bicalutamide Value 2015-2020 ($ Millions)
Figure 36. Americas Bicalutamide Consumption Market Share by Countries in 2019
Figure 37. Americas Bicalutamide Value Market Share by Countries in 2019
Figure 38. Americas Bicalutamide Consumption Market Share by Type in 2019
Figure 39. Americas Bicalutamide Consumption Market Share by Application in 2019
Figure 40. United States Bicalutamide Consumption Growth 2015-2020 (M Pcs)
Figure 41. United States Bicalutamide Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Bicalutamide Consumption Growth 2015-2020 (M Pcs)
Figure 43. Canada Bicalutamide Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Bicalutamide Consumption Growth 2015-2020 (M Pcs)
Figure 45. Mexico Bicalutamide Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Bicalutamide Consumption Market Share by Countries in 2019
Figure 47. APAC Bicalutamide Value Market Share by Regions in 2019
Figure 48. APAC Bicalutamide Consumption Market Share by Type in 2019
Figure 49. APAC Bicalutamide Consumption Market Share by Application in 2019
Figure 50. China Bicalutamide Consumption Growth 2015-2020 (M Pcs)
Figure 51. China Bicalutamide Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Bicalutamide Consumption Growth 2015-2020 (M Pcs)
Figure 53. Japan Bicalutamide Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Bicalutamide Consumption Growth 2015-2020 (M Pcs)
Figure 55. Korea Bicalutamide Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Bicalutamide Consumption Growth 2015-2020 (M Pcs)
Figure 57. Southeast Asia Bicalutamide Value Growth 2015-2020 ($ Millions)
Figure 58. India Bicalutamide Consumption Growth 2015-2020 (M Pcs)
Figure 59. India Bicalutamide Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Bicalutamide Consumption Growth 2015-2020 (M Pcs)
Figure 61. Australia Bicalutamide Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Bicalutamide Consumption Market Share by Countries in 2019
Figure 63. Europe Bicalutamide Value Market Share by Countries in 2019
Figure 64. Europe Bicalutamide Consumption Market Share by Type in 2019
Figure 65. Europe Bicalutamide Consumption Market Share by Application in 2019
Figure 66. Germany Bicalutamide Consumption Growth 2015-2020 (M Pcs)
Figure 67. Germany Bicalutamide Value Growth 2015-2020 ($ Millions)
Figure 68. France Bicalutamide Consumption Growth 2015-2020 (M Pcs)
Figure 69. France Bicalutamide Value Growth 2015-2020 ($ Millions)
Figure 70. UK Bicalutamide Consumption Growth 2015-2020 (M Pcs)
Figure 71. UK Bicalutamide Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Bicalutamide Consumption Growth 2015-2020 (M Pcs)
Figure 73. Italy Bicalutamide Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Bicalutamide Consumption Growth 2015-2020 (M Pcs)
Figure 75. Russia Bicalutamide Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Bicalutamide Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Bicalutamide Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Bicalutamide Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Bicalutamide Consumption Market Share by Application in 2019
Figure 80. Egypt Bicalutamide Consumption Growth 2015-2020 (M Pcs)
Figure 81. Egypt Bicalutamide Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Bicalutamide Consumption Growth 2015-2020 (M Pcs)
Figure 83. South Africa Bicalutamide Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Bicalutamide Consumption Growth 2015-2020 (M Pcs)
Figure 85. Israel Bicalutamide Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Bicalutamide Consumption Growth 2015-2020 (M Pcs)
Figure 87. Turkey Bicalutamide Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Bicalutamide Consumption Growth 2015-2020 (M Pcs)
Figure 89. GCC Countries Bicalutamide Value Growth 2015-2020 ($ Millions)
Figure 90. Global Bicalutamide Consumption Growth Rate Forecast (2021-2025) (M Pcs)
Figure 91. Global Bicalutamide Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 93. Americas Bicalutamide Value 2021-2025 ($ Millions)
Figure 94. APAC Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 95. APAC Bicalutamide Value 2021-2025 ($ Millions)
Figure 96. Europe Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 97. Europe Bicalutamide Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 99. Middle East & Africa Bicalutamide Value 2021-2025 ($ Millions)
Figure 100. United States Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 101. United States Bicalutamide Value 2021-2025 ($ Millions)
Figure 102. Canada Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 103. Canada Bicalutamide Value 2021-2025 ($ Millions)
Figure 104. Mexico Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 105. Mexico Bicalutamide Value 2021-2025 ($ Millions)
Figure 106. Brazil Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 107. Brazil Bicalutamide Value 2021-2025 ($ Millions)
Figure 108. China Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 109. China Bicalutamide Value 2021-2025 ($ Millions)
Figure 110. Japan Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 111. Japan Bicalutamide Value 2021-2025 ($ Millions)
Figure 112. Korea Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 113. Korea Bicalutamide Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 115. Southeast Asia Bicalutamide Value 2021-2025 ($ Millions)
Figure 116. India Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 117. India Bicalutamide Value 2021-2025 ($ Millions)
Figure 118. Australia Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 119. Australia Bicalutamide Value 2021-2025 ($ Millions)
Figure 120. Germany Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 121. Germany Bicalutamide Value 2021-2025 ($ Millions)
Figure 122. France Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 123. France Bicalutamide Value 2021-2025 ($ Millions)
Figure 124. UK Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 125. UK Bicalutamide Value 2021-2025 ($ Millions)
Figure 126. Italy Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 127. Italy Bicalutamide Value 2021-2025 ($ Millions)
Figure 128. Russia Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 129. Russia Bicalutamide Value 2021-2025 ($ Millions)
Figure 130. Spain Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 131. Spain Bicalutamide Value 2021-2025 ($ Millions)
Figure 132. Egypt Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 133. Egypt Bicalutamide Value 2021-2025 ($ Millions)
Figure 134. South Africa Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 135. South Africa Bicalutamide Value 2021-2025 ($ Millions)
Figure 136. Israel Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 137. Israel Bicalutamide Value 2021-2025 ($ Millions)
Figure 138. Turkey Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 139. Turkey Bicalutamide Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Bicalutamide Consumption 2021-2025 (M Pcs)
Figure 141. GCC Countries Bicalutamide Value 2021-2025 ($ Millions)
Figure 142. AstraZeneca Bicalutamide Market Share (2018-2020)
Figure 143. Apotex Corporation Bicalutamide Market Share (2018-2020)
Figure 144. CORDEN PHARMA GMBH Bicalutamide Market Share (2018-2020)
Figure 145. Actavis Pharma Bicalutamide Market Share (2018-2020)
Figure 146. Sivem Pharmaceuticals Bicalutamide Market Share (2018-2020)
Figure 147. Zeneca GmbH Bicalutamide Market Share (2018-2020)
Figure 148. ANI Pharmaceuticals Bicalutamide Market Share (2018-2020)
Figure 149. Sorres Pharma Bicalutamide Market Share (2018-2020)
Figure 150. Accel Pharma Bicalutamide Market Share (2018-2020)
Figure 151. Fresenius Kabi Bicalutamide Market Share (2018-2020)
Figure 152. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Market Share (2018-2020)
Figure 153. Shanxi Zhendong Pharmaceutical Bicalutamide Market Share (2018-2020)
Figure 154. Zhejiang Haizheng Pharmaceutical Bicalutamide Market Share (2018-2020)
Figure 155. Shanghai Zhaohui Pharmaceutical Bicalutamide Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets